Found 5 matching trials
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke PHASE2 The primary objective of the study is to assess the safety and tolerability...
Show More Location
Chattanooga Center for Neurologic Research
Learn More & Join Trial
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease PHASE1 To assess the safety and efficacy of intravenous (IV) PDA001 infused every ...
Show More Location
Cedars Sinai Medical Center, Inflammatory Bowel Disease Center
Learn More & Join Trial
PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease PHASE2 This Phase 2a study evaluated the efficacy, safety, and tolerability of int...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis PHASE2 The primary objective of the study is to assess the safety and efficacy of ...
Show More Location
Pinnacle Research Group
Learn More & Join Trial
Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis PHASE1 The primary objective of the study is to assess the safety and tolerability...
Show More Location
University of Alabama, Birmingham - Division of Pulmonary, Allergy, and Critical Care Medicine
Learn More & Join Trial